Helping those with ALS in Windsor-Essex and Chatham-Kent since 1983

Research

As part of our mission statement, we contribute to research that will lead to a cure for ALS by providing studentship funding and equipment to Western University.

2024 Education Evening

Dr. Michael Strong will be in Windsor on Tuesday, September 24th to share the recent research breakthrough in the quest to understand, treat, and potentially cure amyotrophic lateral sclerosis.

This event is open to open to those living with ALS, families, health care workers, or anyone who would like to hear one of the world’s leading ALS researchers. Please join us 6pm at The Hospice of Windsor and Essex County at 6038 Empress St. in Windsor, at Administrative Building #600, and RSVP here.

2024 Research Update

In Brain, Volume 147, published in June, Dr. Strong and his team documented that targeting an interaction between two proteins present in ALS-impacted nerve cells was able to halt or reverse the disease's progression. Western News documents more details in their May 13th article, and the Temerty family's Temerty Foundation is investing $10M over 5 years to help translate Dr. Strong's research into potential clinical trials. We continue to support Dr. Strong's research with a recurring endowment for student researchers, and by providing funds for tools like the Lecia SP8 confocal microscope, which was among the tools utilized in this research.

2022 Research Update

Please find the attached article from Dr. Michael Strong that highlights their use of a Leica SP8 confocal microscope, which funds from the ALS Society of Windsor-Essex County were used to purchase.

An animated GIF of a 3D reconstruction created using the Confocal Microscope
A 3D reconstruction created using the Confocal Microscope

2021 Donor Impact

We are happy to share an article from Dr. Michael Strong that outlines the ALS Society's impact through our endowment at Western University.

2019 Research Update

Please find the attached article from Dr. Michael Strong that outlines recent updates in ALS research, and shows how our organization has continued to contribute toward these developments.